General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Screening for ColoRectal Cancer (CRC) is widely recommended because of compelling evidence that it reduces mortality from CRC and that it's cost-effective. In France, there is a national CRC screening programme inviting people aged 50-74 years by mail to consult their General Practitioner (GP) for a free on charge Faecal Occult Blood test deliverance every two years. Participation is a key factor for the screening programs success. High levels of screening uptake and the continued participation to regular screening must be achieved and maintained in the targeted population if the enormous potential of CRC screening is to be realised. Screening rates of various international programs vary widely (20-52%) and the participation is insufficient in the most settings. Therefore, a better understanding of facilitating and hindering factors of patient participation can guide interventions to improve CRC screening rates. They include patients and physicians' factors. One issue is about GPs practice. GP involvement has been shown to improve the participation in the CRC screening. This study aims to assess the effectiveness of an intervention targeting GPs to increase patient participation in the CRC screening. Volunteer GPs will be randomly assigned to either the intervention group or to usual care (control group) and they will be followed one year. The intervention consists in providing every four months to the experimental group a list of their patients who are eligible but did not proceed yet to the screening. In both groups, patient participation in the screening will be measured at the end of the study.
| Condition | Intervention | Phase |
|---|---|---|
|
Colorectal Cancer |
Other: Eligible patients' paper-based reminder |
Phase 0 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Screening |
| Official Title: | Effect of Eligible Patients Paper-based Reminder for General Practitioners on Colorectal Cancer Screening Participation |
- Patient's participation to colorectal cancer screening program [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Patient's status with colorectal cancer screening program to 15th june 2011 with two modalities
- Update: completion of Faecal Occult Blood test or exclusion for medical reason within the duration of the study (The medical exclusions of the program are a personal or family history of Colorectal cancer, Crohn's disease, hemorrhagic rectocolitis, or hereditary nonpolyposis colorectal cancer, a colonoscopy undergone in the 5 previous years or a Fecal Occult Blood test undergone in the 2 previous years)
- Not update
| Estimated Enrollment: | 8140 |
| Study Start Date: | June 2010 |
| Estimated Study Completion Date: | June 2011 |
| Estimated Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Eligible patients' paper-based reminder |
Other: Eligible patients' paper-based reminder
Providing to the general practitioners every four months a list of their patients who are eligible for colorectal cancer screening but did not proceed yet and were not excluded for medical reason
|
Eligibility| Ages Eligible for Study: | 50 Years to 74 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
General Practitioner (GP)
- exercising in the Val de Marne (French department of the suburb of Paris)
- volunteered to participate at the study
Patient
- living in the Val de Marne (French department of the suburb of Paris)
- having declared a 'preferred GP' exercising in the Val de Marne to the main statutory health insurance scheme ("régime général")
- being eligible for colorectal cancer screening (aged 50 to 74 years, not excluded and having not proceed yet to the screening)
- having consulted his 'preferred GP', whatever the reason, during the study period
Exclusion Criteria:
Contacts and Locations| France | |
| Département Universitaire d'Enseignement et de Recherche en Médecine Générale | |
| Créteil, France, 94000 | |
| Principal Investigator: | Julien Le Breton, MD, MPH | DUERMG |
More Information
No publications provided
| Responsible Party: | Julien Le Breton / PI, LIC EA4393 / DUERMG |
| ClinicalTrials.gov Identifier: | NCT01364454 History of Changes |
| Other Study ID Numbers: | DUERMG |
| Study First Received: | May 31, 2011 |
| Last Updated: | June 1, 2011 |
| Health Authority: | France: Committee for the Protection of Personnes |
Keywords provided by Paris 12 Val de Marne University:
|
Colorectal Cancer Screening Faecal Occult Blood test General Practitioners Involvement Patient's Participation Reminder |
Additional relevant MeSH terms:
|
Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |
ClinicalTrials.gov processed this record on May 23, 2013